Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method (Q77900129)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Helicobacter pylori

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

M T Fera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Carbone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A De Sarro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

G Riggio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

V Cusumano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

G B De Sarro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F A Ciliberti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Antimicrobial Agents

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

285-289

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

Helicobacter pylori and peptic ulceration: histopathological aspects

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Activity of cefixime against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

In vitro susceptibility of Helicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Helicobacter pylori therapy: effect on peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Treatment failure of ofloxacin in Campylobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Kill kinetics of antimicrobial agents against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900051-X

7 January 2021

10.1016/S0924-8579(98)00051-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916902%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference